12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga16:06 ET

Poseida Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones11:24 ET · Ratings

Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com

Barron's11:10 ET

Poseida Therapeutics Up Nearly 225%, On Pace For Record High Close -- Data Talk

Dow JonesNov 26 10:03 ET

US Stocks Mixed; Best Buy Posts Downbeat Earnings

BenzingaNov 26 09:48 ET

H.C. Wainwright Downgrades Poseida Therapeutics(PSTX.US) to Hold Rating, Cuts Target Price to $9

Moomoo NewsNov 26 09:32 ET · Ratings